ロード中...
Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers
BACKGROUND: HER2 mutation has been found to be an oncogenic driver gene in non-small cell lung cancers(NSCLC) and HER2-directed therapies have shown promising results in this unique population, while little is known about its association with outcomes of chemotherapy. The aim of this study was to in...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5869778/ https://ncbi.nlm.nih.gov/pubmed/29587667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4277-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|